Home LiteratureArticle Details

PMID: 6340563 Published · ppublish English Clinical Trial Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.

Annals of allergy ·Vol. 50 ·No. 4 ·1983-04-00 ·Pages 245-8

Saccar CL, Green LD, Helsel CL, Niehls ME, Diconcetto JA, Mansmann HC, McGeady SJ

Abstract

暂无摘要

MeSH Terms

Absorption Adult Biological Availability Clinical Trials as Topic Delayed-Action Preparations Drug Administration Schedule Humans Kinetics Male Random Allocation Theophylline/administration & dosage,metabolism

Chemicals

Delayed-Action Preparations Theophylline

Authors & Affiliations

7 authors, click to expand affiliations / ORCID

Saccar C L

Green L D

Helsel C L

Niehls M E

Diconcetto J A

Mansmann H C

McGeady S J

Article Info

Journal

Annals of allergy

Abbr.

Ann Allergy

ISSN

0003-4738

Published

1983-04-00

Pages

245-8

Language

English

Region

United States

NLM ID

0372346

Subset

Grants

NHLBI NIH HHS · 1R01HL/GM27578-01-AIPHRA · United States

CIT NIH HHS · MCT-00921-01-0 · United States

External Links

PubMed source

Analysis Services

Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.

Contact

WeChat Official Account